Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2004 Oct;96(10):678-82; 683-6.
doi: 10.4321/s1130-01082004001000002.

Influence of rofecoxib on experimental colonic carcinogenesis in rats

[Article in English, Spanish]
Affiliations
Free article
Comparative Study

Influence of rofecoxib on experimental colonic carcinogenesis in rats

[Article in English, Spanish]
J F Noguera Aguilar et al. Rev Esp Enferm Dig. 2004 Oct.
Free article

Abstract

Aim: To investigate the effect of a selective cyclooxigenase-2 (COX-2) inhibitor, rofecoxib, in the prevalence of experimental colon tumors in rats.

Experimental design: Experimental study with 35 male Sprague-Dawley rats, divided into four groups: a) control group without experimental manipulation (n = 5); b) pharmacological carcinogenesis with 1-2 dimethylhydrazine dihydrocloride (n = 10); c) pharmacological carcinogenesis and addition of acetylsalicylic acid (AAS) (n = 10); and d) carcinogenesis and addition of rofecoxib (n = 10). Carcinogenesis was induced with 1-2 dimethylhydrazine at a weekly dose of 25 mg/kg for 18 weeks. Colon tumors were isolated at 20 weeks. Antiinflammatory agents were given at a dose of AAS 30 mg/kg and rofecoxib at 3 mg/kg.

Results: The percentage of colonic tumors was significantly reduced in the rofecoxib group. This result was found for all tumors and for the malignant lesions, adenocarcinomas.

Conclusions: Rofecoxib, a selective COX-2 inhibitor, reduced the percentage of drug-induced neoplastic glandular tissue in rats.

PubMed Disclaimer

Comment in

  • Colorectal cancer and Coxibs.
    Taxonera C, Mendoza JL. Taxonera C, et al. Rev Esp Enferm Dig. 2004 Oct;96(10):673-5; 675-7. doi: 10.4321/s1130-01082004001000001. Rev Esp Enferm Dig. 2004. PMID: 15537373 English, Spanish. No abstract available.

Publication types

LinkOut - more resources